United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 19,075 United Therapeutics Corporation shares (Form 4)

Traded Mar 13 to Apr 15, 2026 · Filed Apr 16, 2026

From Mar 13 to Apr 15, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 19,075 United Therapeutics Corporation shares at an average US$579.69 for US$11.1M under a trading plan, leaving 40,513 shares. Filed Apr 16, 2026 (Form 4).

Sold
19,075 shares
Price
US$579.69 average (US$536.95 to US$584.24)
Value
US$11.1M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 13, 2026Common StockSale75US$536.95324,443Indirect
Apr 14, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 14, 2026Common StockSale280US$574.2549,733Direct
Apr 14, 2026Common StockSale404US$575.2549,329Direct
Apr 14, 2026Common StockSale80US$575.9049,249Direct
Apr 14, 2026Common StockSale1,360US$577.6247,889Direct
Apr 14, 2026Common StockSale1,164US$578.4146,725Direct
Apr 14, 2026Common StockSale1,580US$579.6545,145Direct
Apr 14, 2026Common StockSale3,675US$580.5541,470Direct
Apr 14, 2026Common StockSale957US$581.5040,513Direct
Apr 15, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 15, 2026Common StockSale80US$575.2949,933Direct
Apr 15, 2026Common StockSale880US$576.9849,053Direct
Apr 15, 2026Common StockSale629US$577.8148,424Direct
Apr 15, 2026Common StockSale684US$579.1447,740Direct
Apr 15, 2026Common StockSale2,255US$580.0245,485Direct
Apr 15, 2026Common StockSale2,819US$581.0542,666Direct
Apr 15, 2026Common StockSale1,624US$582.0541,042Direct
Apr 15, 2026Common StockSale202US$583.4140,840Direct
Apr 15, 2026Common StockSale327US$584.2440,513Direct

Source

View original at SEC

Related